Has Raymond Hwang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,075,294 in general payments to Raymond Hwang, MD across 603 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raymond Hwang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raymond Hwang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raymond Hwang, MD

Orthopaedic Surgery of the Spine · Chestnut Hill, MANPI 1316060437

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (50.6%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Globus Medical at 50.6% of the total. Among orthopaedic surgery of the spine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,075,294in general payments, 2019–2025

Across 603 payments — averaging $1783.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Globus Medical$544K
Medtronic$359K
Bioventus LLC$68K
Vertex$60K
Depuy Synthes Products, Inc.$17K
4web, Inc.$16K
plus $10K from 7 others

$25,410in research payments, 2019–2025

Across 2 payments — averaging $12,705 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bioventus LLC$25K

$67,224in ownership & investment interests, 2019–2025

Across 1 payment — averaging $67,224 each. An ownership or investment interest held by the physician or an immediate family member.

Restor3d, Inc.$67K

What the payments were for

Royalty or licence$543,81751%
Consulting fees$127,72712%
Speaking & faculty fees$341,86632%
Travel & lodging$51,7985%
Food & beverage$10,0871%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Globus Medical(2 entities)	46	$544,157
Medtronic(2 entities)	395	$358,990
Bioventus LLC	62	$68,131
Vertex	63	$60,272
Depuy Synthes Products, Inc.	12	$17,180
4web, Inc.	5	$16,371
Restor3d, Inc.	5	$9,366
Orthofix Medical, Inc.	8	$234
Zimmer Biomet	2	$205
Pacira Pharmaceuticals Incorporated	1	$157
Augmedics Inc.	1	$143
Stryker	2	$60
Smith+Nephew	1	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

COHERE$496,613
COALESCE$423,859
MAZOR X SYSTEM$197,473
JOURNAVX$59,076
CD HORIZON$45,053
CoRoent$27,559
MazorX - Renaissance$24,789
Mazor X Stealth Edition$21,138
STEALTH AUTOGUIDE SYSTEM$20,313
BoneScalpel$18,583
SPINE TRUSS SYSTEM$16,290
StealthStation$10,509
O-ARM$9,475
OsteoAMP$7,103
O-ARM-ST$5,476
PIVOX Oblique Lateral Spinal System$3,668
CD HORIZON SPINAL SYSTEM$2,732
EXCELSIUS$1,212
UNID_PASS$768
Xvision$714

How this compares

$1,075,294 in reported general payments places this provider in the 95th percentile of 28 orthopaedic surgery of the spine providers in Massachusetts.

See all orthopaedic surgery of the spine providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$17,975

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery of the spine in Chestnut Hill

Paul GlazerChestnut Hill$2.1M
Stephen ParazinChestnut Hill$4K
Robert BancoWellesley Hills$661K
Mitchell HardenbrookHopedale$542K
Steven LeckiePlymouth$316K
Jeremy ShorePeabody$232K
Richard OzunaPeabody$198K
Nikhil ThakurNorth Andover$118K
Chadi TannouryBoston$81K
Bryce BasquesRaynham$72K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →